Qarziba – Dinutuximab beta uses, dose and side effects
Qarziba contains dinutuximab beta, which belongs to a group of medicines called “monoclonal antibodies”. These are proteins that you specifically recognize and bind to other unique proteins in your body. Dinutuximab beta binds to a molecule found on cancer cells called disialoganglioside 2 (GD2). This activates the body’s immune system so that it attacks the cancer cells.
Read More